Case Report
Copyright ©The Author(s) 2022.
World J Clin Cases. Nov 16, 2022; 10(32): 11955-11966
Published online Nov 16, 2022. doi: 10.12998/wjcc.v10.i32.11955
Table 3 Cases of cardio-cerebrovascular events caused by stanozolol
Ref.
Biographical information
Drug and dose
Duration of use
Diagnosis
Coronary artery (by CAG or autopsy)
Therapy
Prognosis
[16]30-year-old maleOrally stanozolol 10 mg daily and intramuscularly 250 mg testosterone twice per week2 moAnterior wall AMILADMedical treatmentDischarged
[17]25-year-old maleNandrolone 100 mg/wk stanozolol tablets 25 mg/d3 wkTakotsubo cardiomyopathyNMedical treatmentDischarged
[18]26-year-old maleStanozolol 10 mg daily3 moIschemic StrokeN (Angiography of the Cerebral artery)Medical treatment and rehabilitationDischarged with severe disability
[19]28-year-old maleStanozolol 280mg weekly2 yrNSTEMI; ventricular tachycardiaLADRCAPercutaneous translumind coronary angioplastyDischarged
[20]22-year-old maleStanozolol, 10 mg/d and clenbuterol 40 μg/d for 7 dstanozolol, 20 mg/d and clenbuterol 80 μg/d for 3 d. triiodothy-ronine 25ug/d10 dCardiomyopathy; acute hepatic injuryNSMedical treatmentDischarged
[21]29-year-old femaleEphedrine, tadalafil, metandienon, mestanolon, stanozololNSSudden cardiac death; cardiac arrhythmiaLADNASudden cardiac death
[22]24-year-old maleStanozolol, testosterone, tamoxifen, mesterolone, and nandrolone6 moCardiorespiratoryarrestThe left main trunk and LADNASudden cardiac death
[23]24-year-old maleStanozolol (40 mgs daily) nandrolone 200 mgs intramuscularly twice weekly, Sustanon 250 (testosterone esters) 1 mL intramuscularly once a week6 wkAnterior wall AMI NSMedical treatmentNS
[24]37-year-old maleNandrolone Testosterone cypionate stanozolol; oxandrolone 3-16 wkInferior wall AMIN; Consider spasmMedical treatmentDischarged